Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,678
Closed -$52.5K 2852
2023
Q2
$52.5K Sell
1,678
-8,977
-84% -$205K ﹤0.01% 1603
2023
Q1
$243K Buy
+10,655
New +$274K ﹤0.01% 1421
2022
Q3
Sell
-11,500
Closed -$428K 1714
2022
Q2
$428K Sell
11,500
-600
-5% -$23.3K ﹤0.01% 1211
2022
Q1
$548K Sell
12,100
-10,699
-47% -$468K ﹤0.01% 1010
2021
Q4
$1.1M Buy
+22,799
New +$1.15M ﹤0.01% 898

Other funds holding SRDX

Steven Cohen's SRDX Position: Q3 2023 in Review

Steven Cohen sold out of Surmodics (SRDX) in Q3 2023, closing a stake of 1,678 shares — an estimated $52.5K sold.

Steven Cohen first reported a position in SRDX in Q4 2021 and held it in 5 quarters. The position peaked at $1.1M in Q4 2021. 103 funds tracked by Wall St. Rank hold SRDX as of Q3 2023.

  • Steven Cohen reported no remaining Surmodics position as of Q3 2023 after selling out during the quarter.
  • Steven Cohen sold 1,678 Surmodics shares in Q3 2023, an estimated $52.5K.
  • Steven Cohen first reported a position in Surmodics in Q4 2021 and held it in 5 quarters.
  • Steven Cohen's Surmodics position peaked at $1.1M in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Surmodics as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.